𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma

✍ Scribed by Spiros G. Delis; Andreas Bakoyiannis; Ioannis Biliatis; Konstantinos Athanassiou; Nikos Tassopoulos; Christos Dervenis

Book ID
111220963
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
208 KB
Volume
11
Category
Article
ISSN
1365-182X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Determination of the optimal model for e
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy
✍ Teh-Ia Huo; Jaw-Ching Wu; Han-Chieh Lin; Fa-Yauh Lee; Ming-Chih Hou; Yi-Hsiang H πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

The model for end-stage liver disease (MELD) has been a prevailing system to prioritize cirrhotic patients awaiting liver transplantation. An "exceptional" MELD score of 20 and 24 points is assigned for stage T1 and T2 patients with small hepatocellular carcinoma (HCC), respectively. However, this s

The model for end-stage liver disease sc
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end-stage liver disease: A prospective cohort study
✍ Javier Murillas; Antonio Rimola; Montserrat Laguno; Elisa de Lazzari; Javier Ras πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par